# The role of Akkermansia muciniphila in cancer: Mechanisms, therapeutic potential, and challenges

## TL;DR

Akkermansia muciniphila is a gut bacterium with potential to both promote and prevent cancer, depending on factors like gut health and diet.

## Contribution

This paper explores the dual role of A. muciniphila in cancer and highlights the need for further research to understand its mechanisms and therapeutic use.

## Key findings

- A. muciniphila can influence tumor progression and immune responses in the gut.
- Its effects on cancer are context-dependent, including both tumorigenic and anticancer properties.
- More research is needed to determine how to optimally use A. muciniphila in cancer therapy.

## Abstract

Akkermansia muciniphila (A. muciniphila), regarded as a promising candidate for next‐generation probiotic applications, predominantly inhabits the intestinal mucus layer, where it plays a crucial role in maintaining gut barrier integrity and modulating immune responses. Recently, the bacterium has been recognized for its ambivalent influence on cancer, impacting both tumor progression and therapeutic interventions. Research indicates that A. muciniphila might possess both tumorigenic and anticancer capabilities, influenced by factors such as the composition of the gut microbiota, dietary modifications, and immune modulation. There is a compelling need for further studies to uncover the precise mechanisms and optimal use of A. muciniphila in oncology and beyond.